Lantern Pharma Inc (LTRN)
6.13
-0.01
(-0.16%)
USD |
NASDAQ |
May 17, 16:00
6.13
0.00 (0.00%)
After-Hours: 18:59
Lantern Pharma Price to Book Value: 1.844 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 1.847 |
| May 15, 2024 | 1.904 |
| May 14, 2024 | 1.862 |
| May 13, 2024 | 1.832 |
| May 10, 2024 | 1.853 |
| May 09, 2024 | 2.049 |
| May 08, 2024 | 1.949 |
| May 07, 2024 | 1.931 |
| May 06, 2024 | 2.061 |
| May 03, 2024 | 1.85 |
| May 02, 2024 | 1.652 |
| May 01, 2024 | 1.621 |
| April 30, 2024 | 1.534 |
| April 29, 2024 | 1.483 |
| April 26, 2024 | 1.654 |
| April 25, 2024 | 1.642 |
| April 24, 2024 | 1.618 |
| April 23, 2024 | 1.736 |
| April 22, 2024 | 1.721 |
| April 19, 2024 | 1.606 |
| April 18, 2024 | 1.736 |
| April 17, 2024 | 1.802 |
| April 16, 2024 | 1.805 |
| April 15, 2024 | 1.796 |
| April 12, 2024 | 1.922 |
| Date | Value |
|---|---|
| April 11, 2024 | 2.006 |
| April 10, 2024 | 2.328 |
| April 09, 2024 | 2.334 |
| April 08, 2024 | 2.343 |
| April 05, 2024 | 2.334 |
| April 04, 2024 | 2.172 |
| April 03, 2024 | 2.599 |
| April 02, 2024 | 2.752 |
| April 01, 2024 | 2.861 |
| March 28, 2024 | 2.311 |
| March 27, 2024 | 2.568 |
| March 26, 2024 | 2.634 |
| March 25, 2024 | 2.605 |
| March 22, 2024 | 2.796 |
| March 21, 2024 | 2.371 |
| March 20, 2024 | 2.311 |
| March 19, 2024 | 1.967 |
| March 18, 2024 | 2.615 |
| March 15, 2024 | 2.284 |
| March 14, 2024 | 1.930 |
| March 13, 2024 | 1.809 |
| March 12, 2024 | 2.022 |
| March 11, 2024 | 1.660 |
| March 08, 2024 | 2.172 |
| March 07, 2024 | 1.746 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5936
Minimum
Oct 31 2023
173.31
Maximum
Jun 11 2020
4.090
Average
1.123
Median
Dec 02 2021
Price to Book Value Benchmarks
| Eyenovia Inc | 3.949 |
| Cassava Sciences Inc | 14.12 |
| Alpine Immune Sciences Inc | 13.40 |
| Clearside Biomedical Inc | -- |
| Poseida Therapeutics Inc | 3.655 |
Price to Book Value Related Metrics
| Price | 6.13 |
| Earnings Yield | -26.59% |
| Market Cap | 65.95M |